Gabather AB (publ) (GABA.ST) Research

Gabather AB (publ) is dedicated to creating innovative pharmaceutical solutions for a range of central nervous system disorders. The company's focus includes developing medications for conditions such as psychotic illnesses, mood and anxiety disorders, pain relief, and cognitive function enhancement, notably those related to Alzheimer's disease. Founded in 2014, its operations are headquartered in Södertälje, Sweden.

Market snapshot

Symbol
GABA.ST
Price
$0.04
Day change
+1.07%
Market cap
$8.9M
P/E ratio
-1.83x
52-week range
0.023-0.13
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Chordate Medical Holding AB (publ) (CMH.ST)
  • Fluicell AB (publ) (FLUI.ST)
  • LIDDS AB (publ) (LIDDS.ST)
  • ODI Pharma AB (ODI.ST)
  • ProstaLund AB (publ) (PLUN.ST)
  • Quia Pharma AB (publ) (QUIA.ST)
  • S2Medical AB (publ) (S2M.ST)
  • Spermosens AB (SPERM.ST)

Open Gabather AB (publ) (GABA.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.